These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 21745731)

  • 21. Failure of aspirin to impair bovine platelet function.
    Gentry PA; Tremblay RR; Ross ML
    Am J Vet Res; 1989 Jun; 50(6):919-22. PubMed ID: 2764343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of two doses of aspirin on thromboxane biosynthesis and platelet function in patients undergoing coronary surgery.
    Brambilla M; Parolari A; Camera M; Colli S; Eligini S; Centenaro C; Anselmo A; Alamanni F; Tremoli E
    Thromb Haemost; 2010 Mar; 103(3):516-24. PubMed ID: 20076848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-dose enteric-coated aspirin: a practical approach to continuous-release low-dose aspirin and presystemic acetylation of human platelet cyclooxygenase.
    Jakubowski JA; Stampfer MJ; Vaillancourt R; Faigel D; Deykin D
    J Lab Clin Med; 1986 Dec; 108(6):616-21. PubMed ID: 3097223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aspirin and human platelets: from clinical trials to acetylation of cyclooxygenase and back.
    Patrono C
    Trends Pharmacol Sci; 1989 Nov; 10(11):453-8. PubMed ID: 2514478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Divergence between the pharmacologic and clinical effects of inhibitors of prostaglandin synthesis].
    Rhyner K; Stenger M; Block LH
    Dtsch Med Wochenschr; 1984 Aug; 109(31-32):1211-4. PubMed ID: 6430669
    [No Abstract]   [Full Text] [Related]  

  • 26. Towards a definition of aspirin resistance: a typological approach.
    Weber AA; Przytulski B; Schanz A; Hohlfeld T; Schrör K
    Platelets; 2002 Feb; 13(1):37-40. PubMed ID: 11918835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optical platelet aggregation versus thromboxane metabolites in healthy individuals and patients with stable coronary artery disease after low-dose aspirin administration.
    Hedegaard SS; Hvas AM; Grove EL; Refsgaard J; Rocca B; Daví G; Kristensen SD
    Thromb Res; 2009 May; 124(1):96-100. PubMed ID: 19215971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Mechanism of changes in the platelet functional activity caused by low energy laser irradiation].
    Spasov AA; Nedogoda VV; Konan K
    Biull Eksp Biol Med; 1998 Jul; 126(7):45-8. PubMed ID: 9777195
    [No Abstract]   [Full Text] [Related]  

  • 29. Plasma levels of salicylate and aspirin in healthy volunteers: relevance to drug interaction on platelet function.
    Cerletti C; Bonati M; del Maschio A; Galletti F; Dejana E; Tognoni G; de Gaetano G
    J Lab Clin Med; 1984 Jun; 103(6):869-77. PubMed ID: 6726057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease.
    Lordkipanidzé M; Pharand C; Schampaert E; Turgeon J; Palisaitis DA; Diodati JG
    Eur Heart J; 2007 Jul; 28(14):1702-8. PubMed ID: 17569678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monitoring the entry of new platelets into the circulation after ingestion of aspirin.
    Di Minno G; Silver MJ; Murphy S
    Blood; 1983 Jun; 61(6):1081-5. PubMed ID: 6404326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mediation of cardiac ischemia by thromboxanes released from human platelets.
    Addonizio VP; Wetstein L; Fisher CA; Feldman P; Strauss JF; Harken AH
    Surgery; 1982 Aug; 92(2):292-8. PubMed ID: 7048597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective COX-2 inhibition and cardiovascular effects: a review of the rofecoxib development program.
    Weir MR; Sperling RS; Reicin A; Gertz BJ
    Am Heart J; 2003 Oct; 146(4):591-604. PubMed ID: 14564311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of platelet function tests and thromboxane metabolites to evaluate aspirin response in healthy individuals and patients with coronary artery disease.
    Grove EL; Hvas AM; Johnsen HL; Hedegaard SS; Pedersen SB; Mortensen J; Kristensen SD
    Thromb Haemost; 2010 Jun; 103(6):1245-53. PubMed ID: 20352155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dose- and time-dependent antiplatelet effects of aspirin.
    Perneby C; Wallén NH; Rooney C; Fitzgerald D; Hjemdahl P
    Thromb Haemost; 2006 Apr; 95(4):652-8. PubMed ID: 16601836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High glucose contributes to aspirin insensitivity in streptozotocin-diabetic rats: a multiparametric aggregation study.
    Watala C; Ulicna O; Golanski J; Nocun M; Waczulíková I; Markuszewski L; Drzewoski J
    Blood Coagul Fibrinolysis; 2006 Mar; 17(2):113-24. PubMed ID: 16479193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacodynamic effects of different aspirin dosing regimens in type 2 diabetes mellitus patients with coronary artery disease.
    Capodanno D; Patel A; Dharmashankar K; Ferreiro JL; Ueno M; Kodali M; Tomasello SD; Capranzano P; Seecheran N; Darlington A; Tello-Montoliu A; Desai B; Bass TA; Angiolillo DJ
    Circ Cardiovasc Interv; 2011 Apr; 4(2):180-7. PubMed ID: 21386092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overestimation of platelet aspirin resistance detection by thrombelastograph platelet mapping and validation by conventional aggregometry using arachidonic acid stimulation.
    Tantry US; Bliden KP; Gurbel PA
    J Am Coll Cardiol; 2005 Nov; 46(9):1705-9. PubMed ID: 16256872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of human blood platelet aggregation and the stimulation of nitric oxide synthesis by aspirin.
    Chakraborty K; Khan GA; Banerjee P; Ray U; Sinha AK
    Platelets; 2003; 14(7-8):421-7. PubMed ID: 14713511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid return of cyclo-oxygenase active platelets in dogs after a single oral dose of aspirin.
    Rao GH; Johnson GJ; Reddy RK; White JG
    Prostaglandins; 1981 Nov; 22(5):761-72. PubMed ID: 6799989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.